BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26406287)

  • 1. A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial.
    Wiltink LM; Marijnen CA; Meershoek-Klein Kranenbarg E; van de Velde CJ; Nout RA
    Acta Oncol; 2016; 55(4):502-8. PubMed ID: 26406287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.
    Chen TY; Wiltink LM; Nout RA; Meershoek-Klein Kranenbarg E; Laurberg S; Marijnen CA; van de Velde CJ
    Clin Colorectal Cancer; 2015 Jun; 14(2):106-14. PubMed ID: 25677122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial.
    Wiltink LM; Chen TY; Nout RA; Kranenbarg EM; Fiocco M; Laurberg S; van de Velde CJ; Marijnen CA
    Eur J Cancer; 2014 Sep; 50(14):2390-8. PubMed ID: 25060825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
    J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
    Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.
    Marijnen CA; van de Velde CJ; Putter H; van den Brink M; Maas CP; Martijn H; Rutten HJ; Wiggers T; Kranenbarg EK; Leer JW; Stiggelbout AM
    J Clin Oncol; 2005 Mar; 23(9):1847-58. PubMed ID: 15774778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for faecal incontinence after rectal cancer treatment.
    Lange MM; den Dulk M; Bossema ER; Maas CP; Peeters KC; Rutten HJ; Klein Kranenbarg E; Marijnen CA; van de Velde CJ;
    Br J Surg; 2007 Oct; 94(10):1278-84. PubMed ID: 17579345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of radiation and surgery on function and quality of life (QOL) in rectal cancer patients.
    Wang L; Wang X; Lo A; Raval M; Brown C; Karimuddin A; Phang PT
    Am J Surg; 2018 May; 215(5):863-866. PubMed ID: 29366486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late side effects and quality of life after radiotherapy for rectal cancer.
    Bruheim K; Guren MG; Skovlund E; Hjermstad MJ; Dahl O; Frykholm G; Carlsen E; Tveit KM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1005-11. PubMed ID: 19540058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy.
    van den Brink M; Stiggelbout AM; van den Hout WB; Kievit J; Klein Kranenbarg E; Marijnen CA; Nagtegaal ID; Rutten HJ; Wiggers T; van de Velde CJ
    J Clin Oncol; 2004 Oct; 22(19):3958-64. PubMed ID: 15459218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intraoperative monitoring of pelvic autonomic nerves during TME to prevent urogenital and anorectal dysfunction in rectal cancer patients (NEUROS): a randomized controlled trial.
    Kauff DW; Kronfeld K; Gorbulev S; Wachtlin D; Lang H; Kneist W
    BMC Cancer; 2016 May; 16():323. PubMed ID: 27209237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected rectal cancer after TEM: outcome of completion surgery compared with primary TME.
    van Gijn W; Brehm V; de Graaf E; Neijenhuis PA; Stassen LP; Leijtens JW; Van De Velde CJ; Doornebosch PG
    Eur J Surg Oncol; 2013 Nov; 39(11):1225-9. PubMed ID: 23972571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
    Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
    J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of fecal and urinary incontinence after total mesorectal excision for rectal cancer based on cadaveric surgery: a study from the Cooperative Clinical Investigators of the Dutch total mesorectal excision trial.
    Wallner C; Lange MM; Bonsing BA; Maas CP; Wallace CN; Dabhoiwala NF; Rutten HJ; Lamers WH; Deruiter MC; van de Velde CJ;
    J Clin Oncol; 2008 Sep; 26(27):4466-72. PubMed ID: 18802159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial.
    Marijnen CA; Kapiteijn E; van de Velde CJ; Martijn H; Steup WH; Wiggers T; Kranenbarg EK; Leer JW;
    J Clin Oncol; 2002 Feb; 20(3):817-25. PubMed ID: 11821466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
    Kapiteijn E; Putter H; van de Velde CJ;
    Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.
    Kusters M; Marijnen CA; van de Velde CJ; Rutten HJ; Lahaye MJ; Kim JH; Beets-Tan RG; Beets GL
    Eur J Surg Oncol; 2010 May; 36(5):470-6. PubMed ID: 20096534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.
    Temple LK; Bacik J; Savatta SG; Gottesman L; Paty PB; Weiser MR; Guillem JG; Minsky BD; Kalman M; Thaler HT; Schrag D; Wong WD
    Dis Colon Rectum; 2005 Jul; 48(7):1353-65. PubMed ID: 15868235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.